血液透析/腹膜透析の世界市場...市場調査レポートについてご紹介

1 Introduction (Page No. – 22)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders

2 Research Methodology (Page No. – 26)
2.1 Introduction
2.1.1 Research Methodology Steps
2.1.2 Secondary and Primary Research Methodology
2.1.2.1 Secondary Research
2.1.2.1.1 Key Data From Secondary Sources
2.1.2.2 Primary Research
2.1.2.2.1 Key Data From Primary Sources
2.1.2.2.2 Key Industry Insights
2.1.2.2.2.1 Supply Side
2.1.2.2.2.2 Demand Side
2.1.3 Market Size Estimation Methodology
2.1.3.1 Estimation of Dialysis Procedural Volume
2.1.3.2 Research Methodology: Top-Down Approach {For Market Size Estimation of HD and PD Disposables (Bloodline Sets, Dialyzers, Catheters, Transfer Sets, and Concentrates/Dialysates)}
2.1.3.3 Research Methodology: Top-Down Approach (For Market-Size Estimation of HD/PD Machines)
2.1.3.4 Research Methodology: Bottom-Up Approach (For HD and PD Dialysis Products Market)
2.1.3.5 Research Methodology: Bottom-Up Approach (For HD and PD Dialysis Services Market)
2.1.4 Research Design
2.1.5 Market Data Validation and Triangulation
2.1.6 Assumptions for the Study

3 Executive Summary (Page No. – 41)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 47)
4.1 Dialysis Market Overview
4.2 Regional Analysis: Dialysis Market, By Modality, 2015 vs 2020 (USD Billion)
4.3 Regional Analysis: Dialysis Market, By End User, 2013–2020 (USD Billion)
4.4 Regional Analysis: Dialysis Market, By Products & Services, 2015 vs 2020 (USD Billion)
4.5 Regional Analysis: Peritoneal Dialysis Market, By Modality, 2015 vs 2020 (USD Billion)

5 Market Overview (Page No. – 52)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increasing Number of ESRD Patients
5.3.1.2 Growing Number of Patients Suffering From Diabetes and Hypertension
5.3.1.3 Rise in Aging Population
5.3.1.4 Rising Adoption of Dialysis Procedures Over Renal Transplants
5.3.1.4.1 Low Preference of Patients for Kidney Transplantation
5.3.1.5 Technological Advancements and New Product Launches
5.3.1.5.1 Rising R&D Expenditure for the Development of New Dialysis Products
5.3.1.6 Substantial Healthcare Expenditure on the Treatment of End-Stage Renal Disease
5.3.2 Restraints
5.3.2.1 Risks and Complications Associated With Dialysis
5.3.2.1.1 High Risk and Complications Related to Vascular Access
5.3.2.2 Product Recalls
5.3.2.3 Limited Reimbursements for Dialysis in Developing Countries
5.3.2.4 Reimbursement Cuts for Dialysis in North America
5.3.2.5 Stringent Regulatory Policies for the Approval of New Dialysis Products
5.3.3 Opportunities
5.3.3.1 Emerging Markets Offer Lucrative Growth Opportunities
5.3.3.2 Evolution of User-Friendly and Low-Cost Dialysis Products
5.3.3.3 Increasing Number of Dialysis Centers
5.3.3.4 Growing Adoption of Home Hemodialysis Treatment
5.3.4 Challenges
5.3.4.1 Benefits of Renal Transplantation Versus Dialysis
5.3.4.1.1 Low Cost
5.3.4.1.2 Better Patient Survival Rate
5.3.4.2 Sustainability of Players in the Highly Competitive Market
5.3.4.3 High Cost of Dialysis Treatment

6 Competitive Intelligence Analysis (Page No. – 72)
6.1 Porter’s Five Forces Analysis
6.1.1 Segment Rivalry
6.1.2 Threat of Substitutes
6.1.3 Threat of New Entrants
6.1.4 Supplier’s Bargaining Power
6.1.5 Buyer’s Bargaining Power
6.2 Competitive Intensity: Dialysis Products Market
6.2.1 Evaluation Parameters and Scores
6.2.2 Scoring Methodology
6.2.3 Competitive Intensity Score, By Company
6.2.3.1 Baxter
6.2.3.2 Fresenius
6.2.3.3 B. Braun
6.2.4 Competitive Intensity – Mapping of Baxter, B.Braun, and Fresenius
6.3 Dialysis Products and Services Market: Empirical Assessment of Growth Strategies
6.3.1 Path Towards Strategic Development – Organic and Inorganic Growth Strategies
6.3.2 Dialysis Products Market
6.3.2.1 Organic Growth Strategies
6.3.2.2 Inorganic Growth Strategies
6.3.3 Dialysis Services Market
6.3.3.1 Organic Growth Strategies
6.3.3.2 Inorganic Growth Strategies

7 Industry Insights (Page No. – 87)
7.1 Introduction
7.2 Industry Trends
7.2.1 Wearable and Miniature Dialysis Machines – A New Dawn of Dialysis
7.2.2 Consolidation of the Dialysis Services Market
7.2.3 Ongoing Partnerships Among Dialysis Products and Services Providers
7.2.4 Continuing Robust Private Equity Activity
7.2.5 Increasing Trend Towards Private Dialysis Providers
7.3 Reimbursement Scenario
7.3.1.1 North America
7.3.1.2 Europe
7.3.1.2.1 Germany
7.3.1.2.2 France
7.3.1.2.3 Belgium
7.3.1.2.4 U.K.
7.3.1.2.5 Netherlands
7.3.1.3 Asia-Pacific
7.3.1.3.1 Asian Region (Except Japan)
7.3.1.3.2 Japan
7.3.1.3.3 Pacific Region:
7.3.1.4 Rest of the World
7.3.1.4.1 Latin America
7.3.1.4.2 Africa
7.4 Regulatory Landscape
7.4.1.1 North America
7.4.1.1.1 U.S.
7.4.1.1.2 Canada
7.4.1.2 Europe
7.4.1.3 Asia-Pacific
7.4.1.3.1 India
7.4.1.3.2 China
7.4.1.3.3 Japan
7.4.1.3.4 South Korea
7.4.1.4 Rest of the World
7.4.1.4.1 Latin America
7.4.1.4.1.1 Brazil
7.4.1.4.1.2 Argentina
7.4.1.4.1.3 Mexico
7.4.1.4.2 Middle East
7.4.1.4.3 Africa

8 Adoption of Dialysis Modalities, By Region (Page No. – 106)
8.1 Introduction
8.2 Hemodialysis (HD) Procedures
8.3 Peritoneal Dialysis (PD) Procedures
8.4 Hemodialysis HD vs Peritoneal Dialysis PD

9 Global Hemodialysis Market (Page No. – 113)
9.1 Hemodialysis Market, By Products & Services
9.1.1 Introduction
9.1.2 Hemodialysis Products
9.1.2.1 Hemodialysis Machines
9.1.2.1.1 Center-Use Hemodialysis Machines
9.1.2.1.2 Home-Use Hemodialysis Machines
9.1.2.2 Hemodialysis Consumables/Supplies
9.1.2.2.1 Dialyzers
9.1.2.2.2 Dialyzers Market, By Material Type
9.1.2.2.2.1 Cellulose-Based Dialyzers
9.1.2.2.2.2 Synthetic Dialyzers
9.1.2.2.3 Dialyzers Market, By Flux Type
9.1.2.2.3.1 High-Flux Dialyzers
9.1.2.2.3.2 Low-Flux Dialyzers
9.1.2.2.4 Hemodialysis Access Products
9.1.2.2.4.1 Arteriovenous (AV) Fistula
9.1.2.2.4.2 A-V Graft
9.1.2.2.4.3 Central Venous Catheter (CVC)
9.1.2.2.5 Bloodlines
9.1.2.2.6 Hemodialysis Concentrates/Dialysates
9.1.2.2.7 Other Hemodialysis Consumables
9.1.3 Hemodialysis Services
9.1.3.1 In-Center Hemodialysis Services
9.1.3.2 Home Hemodialysis Services
9.2 Hemodialysis Market, By Modality
9.2.1 Conventional Long-Term Hemodialysis
9.2.2 Short Daily Hemodialysis
9.2.3 Nocturnal Hemodialysis
9.3 Water Treatment Systems Market, By Type
9.3.1 Central Water Disinfection Systems Market
9.3.1.1 Chemical Disinfection Systems Market
9.3.1.2 Heat Disinfection Systems
9.3.1.3 Accessories
9.3.2 Portable Water Disinfection Systems Market
9.3.2.1 Chemical Disinfection Systems
9.3.2.2 Heat Disinfection Systems
9.3.2.3 Accessories

10 Global Peritoneal Dialysis Market (Page No. – 158)
10.1 Peritoneal Dialysis Market, By Product and Service
10.1.1 Introduction
10.1.2 Peritoneal Dialysis Products
10.1.2.1 Peritoneal Dialysis Concentrate/Dialysate
10.1.2.2 Peritoneal Dialysis Machines
10.1.2.3 Peritoneal Dialysis Catheters
10.1.2.4 Peritoneal Dialysis Transfer Sets
10.1.2.5 Others
10.1.3 Peritoneal Dialysis Services
10.2 Peritoneal Dialysis Market, By Modality
10.2.1 Continuous Ambulatory Peritoneal Dialysis (CAPD)
10.2.2 Automated Peritoneal Dialysis (APD)

11 Global Dialysis Market, By End User (Page No. – 172)
11.1 Introduction
11.2 In-Center Dialysis
11.2.1 Hospital Dialysis
11.2.2 Independent Dialysis Centers
11.3 Home Dialysis
11.3.1 Peritoneal Dialysis
11.3.2 Home Hemodialysis

12 Global Hemodialysis & Peritoneal Dialysis Market, By Region (Page No. – 183)
12.1 Introduction
12.1.1 North America
12.1.1.1 Consolidation of Markets in North America
12.1.1.2 U.S.
12.1.1.2.1 Bundle Reimbursement, A Strong Incentive for Dialysis Providers to Encourage PD Adoption
12.1.1.2.2 Underutilization of Home HD in the U.S.
12.1.1.3 Canada
12.1.1.3.1 High Government Expenditure for Not-For-Profit Hospitals to Deliver Dialysis Care
12.1.1.3.2 Rising Focus of Provincial Hospitals on Providing Quality Care
12.1.2 Europe
12.1.2.1.1 Wide Variations in Europe for the Adoption of Dialysis
12.1.2.2 Germany
12.1.2.2.1 High Competition in the German Dialysis Market
12.1.2.3 France
12.1.2.3.1 Improvement in Reimbursement Scenario for Dialysis in France
12.1.2.4 U.K.
12.1.2.4.1 The U.K., an Attractive Market for Small Dialysis Players
12.1.2.4.2 Low Utilization of Home Dialysis in the U.K.
12.1.2.5 Rest of Europe
12.1.2.5.1 Huge Growth Potential in Eastern Europe
12.1.3 Asia-Pacific
12.1.3.1 Dialysis Firms Increasingly Focusing on Asia-Pacific
12.1.3.2 High Cost of Treatment and Poor Reimbursement Hindering Utilization of Dialysis
12.1.3.3 Japan
12.1.3.3.1 Low Preference for Kidney Transplantation Driving the Adoption of Dialysis
12.1.3.3.2 High Entry Barriers in Japan for Foreign Players
12.1.3.4 China
12.1.3.4.1 China Halts Anti-Dumping Probe Into Foreign Dialysis Kit Makers
12.1.3.5 India
12.1.3.5.1 Evolving Home Dialysis Treatment in the Country
12.1.3.5.2 Poor Accessibility of Dialysis Treatment
12.1.3.5.3 Dearth of Indigenous Manufacturers for Dialysis Machines and Dialyzers in India
12.1.3.6 Rest of Asia-Pacific (RoAPAC)
12.1.3.6.1 South Korean Dialysis Market is Growing at A High Rate
12.1.3.6.2 Underutilization of Home Dialysis in Australia
12.1.3.6.3 High ESRD Prevalence and Rising Government Focus Driving the Growth of the Taiwanese Dialysis Market
12.1.3.6.4 Effective Promotion of PD in Hong Kong
12.1.4 Rest of the World
12.1.4.1 Latin America
12.1.4.1.1 High Usage of PD in the Latin America
12.1.4.1.2 New Amendments Open Brazilian Dialysis Industry to Foreign Investment
12.1.4.1.3 Mexico Shows the Highest Utilization of PD in the World
12.1.4.2 Middle East
12.1.4.2.1 Rising Government Funding Towards the Treatment of Dialysis is Driving the Market in Saudi Arabia
12.1.4.3 Africa

13 Competitive Landscape (Page No. – 237)
13.1 Overview
13.2 Market Share Analysis, By Key Player
13.2.1 Key Players in the Dialysis Products Market
13.2.2 Key Players in the Dialysis Services Market
13.2.3 Key Players in the Hemodialysis Products Market
13.2.4 Key Players in the Peritoneal Dialysis Products Market
13.3 Competitive Situation and Trends
13.4 Recent Developments
13.4.1 Expansion
13.4.2 Mergers & Acquisitions
13.4.3 Agreements & Partnerships
13.4.4 New Product Launches and Approvals
13.4.5 Other Strategies

14 Company Profiles (Page No. – 251)
14.1 Introduction
14.2 Fresenius Medical Care AG & Co. KGAA
14.2.1 Business Overview
14.2.2 Product Offerings
14.2.3 Service Offerings
14.2.4 Recent Developments (2012–2015)
14.2.5 MnM View
14.3 Davita Healthcare Partners Inc.
14.3.1 Business Overview
14.3.2 Service Offerings
14.3.3 Recent Developments (2012–2015)
14.3.4 MnM View
14.4 Baxter International Inc.
14.4.1 Business Overview
14.4.2 Product Offerings
14.4.3 Service Offerings
14.4.4 Recent Developments (2012–2015)
14.4.5 MnM View
14.5 B. Braun Melsungen AG
14.5.1 Business Overview
14.5.2 Product Offerings
14.5.3 Service Offerings
14.5.4 Recent Developments (2012–2015)
14.5.5 MnM View
14.6 Diaverum Deutschland Gmbh
14.6.1 Business Overview
14.6.2 Service Offerings
14.6.3 Recent Developments (2012–2015)
14.6.4 MnM View
14.7 Nipro Corporation
14.7.1 Business Overview
14.7.2 Product Offerings
14.7.3 Recent Developments (2012–2015)
14.8 Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation)
14.8.1 Business Overview
14.8.2 Product Offerings
14.8.3 Service Offerings
14.8.4 Recent Developments (2012–2015)
14.9 Nikkiso Co., Ltd.
14.9.1 Business Overview
14.9.2 Product Offerings
14.9.3 Recent Developments (2012–2015)
14.10 Nxstage Medical, Inc.
14.10.1 Business Overview
14.10.2 Product Offerings
14.10.3 Service Offerings
14.10.4 Recent Developments (2012–2015)
14.11 Mar Cor Purification, Inc. (A Cantel Medical Company)
14.11.1 Business Overview
14.11.2 Product Offerings
14.11.3 Service Offerings
14.11.4 Recent Developments (2012–2015)

15 Appendix (Page No. – 285)
15.1 Insights of Industry Experts
15.2 Discussion Guide
15.3 Introducing RT: Real-Time Market Intelligence
15.4 Available Customizations
15.5 Related Reports